On October 13, 2025, GSK plc purchased 2,904,000 shares as part of its ongoing share buyback program, increasing its total treasury shares to 250,368,844 from a total of 4,065,044,985 issued shares. The buyback reflects GSK’s continued focus on returning value to shareholders and optimizing its capital structure.

In addition, the company filed a transaction notification regarding the shareholdings of a director and Persons Discharging Managerial Responsibilities (PDMR). This disclosure ensures compliance with governance regulations and provides transparency about insider transactions within the company.

GSK’s actions highlight its commitment to capital management and regulatory transparency while maintaining shareholder confidence.